Michelle Y Cheng1,2, Gary K Steinberg1,2, Zhijuan Cao1,2, Sean S Harvey1,2, Terrance Chiang1,2, Aulden G Foltz1,2, Alex G Lee3. 1. Department of Neurosurgery (Z.C., S.S.H., T.C., A.G.F., M.Y.C., G.K.S.), Stanford University School of Medicine, CA. 2. Stanford Stroke Center (Z.C., S.S.H., T.C., A.G.F., M.Y.C., G.K.S.), Stanford University School of Medicine, CA. 3. Division of Hematology and Oncology, Department of Pediatrics, University of California, San Francisco (A.G.L.).
Abstract
BACKGROUND AND PURPOSE: Stroke disrupts neuronal functions in both local and remotely connected regions, leading to network-wide deficits that can hinder recovery. The thalamus is particularly affected, with progressive development of neurodegeneration accompanied by inflammatory responses. However, the complexity of the involved inflammatory responses is poorly understood. Herein we investigated the spatiotemporal changes in the secondary degenerative thalamus after cortical stroke, using targeted transcriptome approach in conjunction with histology and flow cytometry. METHODS: Cortical ischemic stroke was generated by permanent occlusion of the left middle cerebral artery in male C57BL6J mice. Neurodegeneration, neuroinflammatory responses, and microglial activation were examined in naive and stroke mice at from poststroke days (PD) 1 to 84, in both ipsilesional somatosensory cortex and ipsilesional thalamus. NanoString neuropathology panel (780 genes) was used to examine transcriptome changes at PD7 and PD28. Fluorescence activated cell sorting was used to collect CD11c+ microglia from ipsilesional thalamus, and gene expressions were validated by quantitative real-time polymerase chain reaction. RESULTS: Neurodegeneration in the thalamus was detected at PD7 and progressively worsened by PD28. This was accompanied by rapid microglial activation detected as early as PD1, which preceded the neurodegenerative changes. Transcriptome analysis showed higher number of differentially expressed genes in ipsilesional thalamus at PD28. Notably, neuroinflammation was the top activated pathway, and microglia was the most enriched cell type. Itgax (CD11c) was the most significantly increased gene, and its expression was highly detected in microglia. Flow-sorted CD11c+ microglia from degenerative thalamus indicated molecular signatures similar to neurodegenerative disease-associated microglia; these included downregulated Tmem119 and CX3CR1 and upregulated ApoE, Axl, LpL, CSF1, and Cst7. CONCLUSIONS: Our findings demonstrate the dynamic changes of microglia after stroke and highlight the importance of investigating stroke network-wide deficits. Importantly, we report the existence of a unique subtype of microglia (CD11c+) with neurodegenerative disease-associated microglia features in the degenerative thalamus after stroke.
BACKGROUND AND PURPOSE: Stroke disrupts neuronal functions in both local and remotely connected regions, leading to network-wide deficits that can hinder recovery. The thalamus is particularly affected, with progressive development of neurodegeneration accompanied by inflammatory responses. However, the complexity of the involved inflammatory responses is poorly understood. Herein we investigated the spatiotemporal changes in the secondary degenerative thalamus after cortical stroke, using targeted transcriptome approach in conjunction with histology and flow cytometry. METHODS: Cortical ischemic stroke was generated by permanent occlusion of the left middle cerebral artery in male C57BL6J mice. Neurodegeneration, neuroinflammatory responses, and microglial activation were examined in naive and stroke mice at from poststroke days (PD) 1 to 84, in both ipsilesional somatosensory cortex and ipsilesional thalamus. NanoString neuropathology panel (780 genes) was used to examine transcriptome changes at PD7 and PD28. Fluorescence activated cell sorting was used to collect CD11c+ microglia from ipsilesional thalamus, and gene expressions were validated by quantitative real-time polymerase chain reaction. RESULTS: Neurodegeneration in the thalamus was detected at PD7 and progressively worsened by PD28. This was accompanied by rapid microglial activation detected as early as PD1, which preceded the neurodegenerative changes. Transcriptome analysis showed higher number of differentially expressed genes in ipsilesional thalamus at PD28. Notably, neuroinflammation was the top activated pathway, and microglia was the most enriched cell type. Itgax (CD11c) was the most significantly increased gene, and its expression was highly detected in microglia. Flow-sorted CD11c+ microglia from degenerative thalamus indicated molecular signatures similar to neurodegenerative disease-associated microglia; these included downregulated Tmem119 and CX3CR1 and upregulated ApoE, Axl, LpL, CSF1, and Cst7. CONCLUSIONS: Our findings demonstrate the dynamic changes of microglia after stroke and highlight the importance of investigating stroke network-wide deficits. Importantly, we report the existence of a unique subtype of microglia (CD11c+) with neurodegenerative disease-associated microglia features in the degenerative thalamus after stroke.
Authors: Michael Schroeter; Philipp Zickler; David T Denhardt; Hans-Peter Hartung; Sebastian Jander Journal: Brain Date: 2006-04-24 Impact factor: 13.501
Authors: Kimberley A Jones; Ihssane Zouikr; Madeleine Patience; Andrew N Clarkson; Jörgen Isgaard; Sarah J Johnson; Neil Spratt; Michael Nilsson; Frederick R Walker Journal: Brain Behav Immun Date: 2015-03-04 Impact factor: 7.217
Authors: Grégory Kuchcinski; Fanny Munsch; Renaud Lopes; Antoine Bigourdan; Jason Su; Sharmila Sagnier; Pauline Renou; Jean-Pierre Pruvo; Brian K Rutt; Vincent Dousset; Igor Sibon; Thomas Tourdias Journal: Brain Date: 2017-07-01 Impact factor: 13.501
Authors: Aleksandra Deczkowska; Hadas Keren-Shaul; Assaf Weiner; Marco Colonna; Michal Schwartz; Ido Amit Journal: Cell Date: 2018-05-17 Impact factor: 41.582
Authors: Timothy R Hammond; Connor Dufort; Lasse Dissing-Olesen; Stefanie Giera; Adam Young; Alec Wysoker; Alec J Walker; Frederick Gergits; Michael Segel; James Nemesh; Samuel E Marsh; Arpiar Saunders; Evan Macosko; Florent Ginhoux; Jinmiao Chen; Robin J M Franklin; Xianhua Piao; Steven A McCarroll; Beth Stevens Journal: Immunity Date: 2018-11-21 Impact factor: 31.745
Authors: Jenni E Anttila; Katrina Albert; Emily S Wires; Kert Mätlik; Lisa C Loram; Linda R Watkins; Kenner C Rice; Yun Wang; Brandon K Harvey; Mikko Airavaara Journal: eNeuro Date: 2018-04-18
Authors: Janelle M Korf; Pedram Honarpisheh; Eric C Mohan; Anik Banerjee; Maria P Blasco-Conesa; Parisa Honarpisheh; Gary U Guzman; Romeesa Khan; Bhanu P Ganesh; Amy L Hazen; Juneyoung Lee; Aditya Kumar; Louise D McCullough; Anjali Chauhan Journal: J Immunol Date: 2022-06-22 Impact factor: 5.426
Authors: Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg Journal: Mol Neurodegener Date: 2022-09-24 Impact factor: 18.879
Authors: Ines Sophie Schädlich; Oliver Schnapauff; Lennart Pöls; Jürgen Schrader; Eva Tolosa; Björn Rissiek; Tim Magnus Journal: iScience Date: 2022-05-26